These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 18042721)

  • 21. Effective network of deep brain stimulation of subthalamic nucleus with bimodal positron emission tomography/functional magnetic resonance imaging in Parkinson's disease.
    Chen HM; Sha ZQ; Ma HZ; He Y; Feng T
    CNS Neurosci Ther; 2018 Feb; 24(2):135-143. PubMed ID: 29222835
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A network analysis of ¹⁵O-H₂O PET reveals deep brain stimulation effects on brain network of Parkinson's disease.
    Park HJ; Park B; Kim HY; Oh MK; Kim JI; Yoon M; Lee JD; Chang JW
    Yonsei Med J; 2015 May; 56(3):726-36. PubMed ID: 25837179
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Abnormal metabolic network activity in Parkinson's disease: test-retest reproducibility.
    Ma Y; Tang C; Spetsieris PG; Dhawan V; Eidelberg D
    J Cereb Blood Flow Metab; 2007 Mar; 27(3):597-605. PubMed ID: 16804550
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dissociation of metabolic and neurovascular responses to levodopa in the treatment of Parkinson's disease.
    Hirano S; Asanuma K; Ma Y; Tang C; Feigin A; Dhawan V; Carbon M; Eidelberg D
    J Neurosci; 2008 Apr; 28(16):4201-9. PubMed ID: 18417699
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modulation of Abnormal Metabolic Brain Networks by Experimental Therapies in a Nonhuman Primate Model of Parkinson Disease: An Application to Human Retinal Pigment Epithelial Cell Implantation.
    Peng S; Ma Y; Flores J; Cornfeldt M; Mitrovic B; Eidelberg D; Doudet DJ
    J Nucl Med; 2016 Oct; 57(10):1591-1598. PubMed ID: 27056614
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Changes in brain glucose metabolism in subthalamic nucleus deep brain stimulation for advanced Parkinson's disease.
    Volonté MA; Garibotto V; Spagnolo F; Panzacchi A; Picozzi P; Franzin A; Giovannini E; Leocani L; Cursi M; Comi G; Perani D
    Parkinsonism Relat Disord; 2012 Jul; 18(6):770-4. PubMed ID: 22591577
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Resting-state functional magnetic resonance imaging of the subthalamic microlesion and stimulation effects in Parkinson's disease: Indications of a principal role of the brainstem.
    Holiga Š; Mueller K; Möller HE; Urgošík D; Růžička E; Schroeter ML; Jech R
    Neuroimage Clin; 2015; 9():264-74. PubMed ID: 26509113
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Frontal FDG-PET activity correlates with cognitive outcome after STN-DBS in Parkinson disease.
    Kalbe E; Voges J; Weber T; Haarer M; Baudrexel S; Klein JC; Kessler J; Sturm V; Heiss WD; Hilker R
    Neurology; 2009 Jan; 72(1):42-9. PubMed ID: 19122029
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Postural instability and gait disorders after subthalamic nucleus deep brain stimulation in Parkinson's disease: a PET study.
    Ahrweiller K; Houvenaghel JF; Riou A; Drapier S; Sauleau P; Haegelen C; Jannin P; Vérin M; Palard X; Le Jeune F
    J Neurol; 2019 Nov; 266(11):2764-2771. PubMed ID: 31350641
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical and cerebral activity changes induced by subthalamic nucleus stimulation in advanced Parkinson's disease: a prospective case-control study.
    Cilia R; Marotta G; Landi A; Isaias IU; Mariani CB; Vergani F; Benti R; Sganzerla E; Pezzoli G; Antonini A
    Clin Neurol Neurosurg; 2009 Feb; 111(2):140-6. PubMed ID: 18995954
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biodistribution and safety assessment of AAV2-GAD following intrasubthalamic injection in the rat.
    Fitzsimons HL; Riban V; Bland RJ; Wendelken JL; Sapan CV; During MJ
    J Gene Med; 2010 Apr; 12(4):385-98. PubMed ID: 20352617
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hemispheric Network Expression in Parkinson's Disease: Relationship to Dopaminergic Asymmetries.
    Tang CC; Holtbernd F; Ma Y; Spetsieris P; Oh A; Fink GR; Timmermann L; Eggers C; Eidelberg D
    J Parkinsons Dis; 2020; 10(4):1737-1749. PubMed ID: 32925097
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Abnormalities in metabolic network activity precede the onset of motor symptoms in Parkinson's disease.
    Tang CC; Poston KL; Dhawan V; Eidelberg D
    J Neurosci; 2010 Jan; 30(3):1049-56. PubMed ID: 20089913
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Attenuation of fluctuating striatal synaptic dopamine levels in patients with Parkinson disease in response to subthalamic nucleus stimulation: a positron emission tomography study.
    Nimura T; Yamaguchi K; Ando T; Shibuya S; Oikawa T; Nakagawa A; Shirane R; Itoh M; Tominaga T
    J Neurosurg; 2005 Dec; 103(6):968-73. PubMed ID: 16381182
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Subthalamic Nucleus Deep Brain Stimulation Modulate Catecholamine Levels with Significant Relations to Clinical Outcome after Surgery in Patients with Parkinson's Disease.
    Yamamoto T; Uchiyama T; Higuchi Y; Asahina M; Hirano S; Yamanaka Y; Kuwabara S
    PLoS One; 2015; 10(9):e0138462. PubMed ID: 26394059
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stimulation sites in the subthalamic nucleus and clinical improvement in Parkinson's disease: a new approach for active contact localization.
    Garcia-Garcia D; Guridi J; Toledo JB; Alegre M; Obeso JA; Rodríguez-Oroz MC
    J Neurosurg; 2016 Nov; 125(5):1068-1079. PubMed ID: 26848922
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Future and current surgical therapies in Parkinson's disease.
    Betchen SA; Kaplitt M
    Curr Opin Neurol; 2003 Aug; 16(4):487-93. PubMed ID: 12869808
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Subthalamic nucleus stimulation effects on single and combined task performance in Parkinson's disease patients: a PET study.
    Atkinson-Clement C; Maillet A; LeBars D; Lavenne F; Redouté J; Krainik A; Pollak P; Thobois S; Pinto S
    Brain Imaging Behav; 2017 Aug; 11(4):1139-1153. PubMed ID: 27704407
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Networks mediating the clinical effects of pallidal brain stimulation for Parkinson's disease: a PET study of resting-state glucose metabolism.
    Fukuda M; Mentis MJ; Ma Y; Dhawan V; Antonini A; Lang AE; Lozano AM; Hammerstad J; Lyons K; Koller WC; Moeller JR; Eidelberg D
    Brain; 2001 Aug; 124(Pt 8):1601-9. PubMed ID: 11459751
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Subthalamic nucleus stimulation affects orbitofrontal cortex in facial emotion recognition: a PET study.
    Le Jeune F; Péron J; Biseul I; Fournier S; Sauleau P; Drapier S; Haegelen C; Drapier D; Millet B; Garin E; Herry JY; Malbert CH; Vérin M
    Brain; 2008 Jun; 131(Pt 6):1599-608. PubMed ID: 18490359
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.